Neuro-Behçet's syndrome: Differential diagnosis and management

Current Rheumatology Reports

Volumn 8, Issue 4, 2006, Pages 317-322

  Diri, Erdal ^a   Espinoza, Louis R ^b  

^a Trinity Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNIMUSTINE;

BEHCET DISEASE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG PULSE THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; NEURO BEHCET SYNDROME; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSPECIFIED SIDE EFFECT;

BEHCET SYNDROME; BRAIN; CENTRAL NERVOUS SYSTEM; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES;

EID: 33750313712     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-006-0016-4     Document Type: Review

References (50)

1. Barnes CG: Treatment of Behcet's syndrome. Rheumatology 2006, 45:245-247. Article reviews general aspects and therapy of Behçet's syndrome well.
2. Uber rezidivierende aphthose durch ein virus verursachte Behçet H. geschwure am mund, am auge und an den genitalien [in German]. Dermatol Wochenschr 1937, 105:1152-1157.
3. Tune R, Keyman E, Melikoglu M, et al.: Target organ associations in Turkish patients with Behcet's disease: a cross sectional study by exploratory factor analysis. J Rheumatol 2002, 29:2393-2396.
4. Yazici H: Behcet's syndrome: Where do we stand? Am J Med 2002, 112:75-76. An editorial from an expert in the area of Behçet's syndrome.
5. Diri E, Mat C, Hamuryudan V, et al.: Papulopustular skin lesions are seen more frequently in patients with Behcet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001, 60:1074-1076.
6. Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med 1999, 341:1284-1291.
7. Kaklamani VG, Vaiopoulos G, Kaklamanis PG: Behcet's disease. Semin Arthritis Rheum 1998, 27:197-217.
8. Poon W, Verity DH, Larkin GL, et al.: Behcet's disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol 2003, 87:876-878.
9. Yurdakul S, Gunaydin I, Tuzun Y, et al.: The prevalence of Behcet's syndrome in a rural area in northern Turkey. J Rheumatol 1988, 15:820-822.
10. Nakae K, Masaki F, Hashimoto T, et al.: Recent epidemiological features of Behçet's disease in Japan. In: Behçet's disease. Edited by Wechsler B, Godeau P. Amsterdam: Excerpta Medica; 1993:145-151.
11. Yazici H, Tuzun Y, Pararli H, et al.: Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis 1984, 43:783-789.
12. Fietta P: Behcet's disease: familial clustering and immunogenetics Clin Exp Rheumatol 2005, 23(Suppl 38):S96-S105. This very comprehensive and detailed article reviews the immunogenetics of Behçet's syndrome.
13. Yazici H, Chamberlain MA, Tuzun Y, et al.: A comparative study of the pathergy reaction among Turkish and British patients with Behcet's disease. Ann Rheum Dis 1984, 43:74-75.
14. Bonfioli AA, Orefice F: Behcet's disease. Semin Ophthalmol 2005, 20:199-206.
15. Atzeni F, Sarzi-Puttini P, Doria A, et al.: Behcet's disease and cardiovascular involvement. Lupus 2005, 14:723-726. Article contains an in-depth review of the cardiovascular involvement in Behçet's syndrome, as well as the authors' own related clinical experience.
16. Melikoglu M, Altiparmak MR, Fresko I, et al.: A reappraisal of amyloidosis in Behcet's syndrome. Rheumatology 2001, 40:212-215.
17. International Study Group for Behcet's Disease: Criteria for diagnosis of Behcet's disease. Lancet 1990, 335:1078-1080.
18. Borhani Haghighi A, Pourmand R, Nikseresht AR: Neuro-Behcet disease: a review. Neurologist 2005, 11:80-89. The authors provide a comprehensive overview of neuro-Behçet's syndrome.
19. Chin RL, Latov N: Central nervous system manifestations of rheumatologic diseases. Curr Opin Rheumatol 2005, 17:91-99. This paper has a good discussion of the differential diagnosis of rheumatic disorders causing central nervous system manifestations.
20. Serdaroglu P, Yazici H, Ozdemir C, et al.: Neurologic involvement in Behcet's syndrome: a prospective study. Arch Neurol 1989, 46:265-269.
21. Akman-Demir G, Serdaroglu P, Tasci B: Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999, 122:2171-2182. This excellent report describes in detail the neurological manifestations in a large population of patients with Behçet's. Prognostic factors are also discussed.
22. Lakhanpal S, Tani K, Lie JT, et al.: Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985, 16:790-795.
23. Kone-Paut I, Gorchakoff-Molinas A, Weschler B, Touitou I: Paediatric Behcet's disease in France [letter]. Ann Rheum Dis 2002, 61:655-656.
24. Siva A, Kantarci OH, Saip S, et al.: Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95-103. This is a well-designed study describing the frequencies of the different neurologic manifestations of Behçet's syndrome.
25. Mirsattari SM, McGinn GJ, Halliday WC: Neuro-Behcet disease with predominant involvement of the brainstem. Neurology 2004, 63:382-384.
26. Kidd D, Steuer A, Denman AM, Rudge P: Neurological complications in Behcet's syndrome. Brain 1999, 122:2183-2194.
27. Davis LE, Hodgin UG, Kornfeld M: Recurrent meningoencephalitis with recovery from Behcet's disease. West J Med 1986, 145:238-239.
28. Aykutlu E, Baykan B, Akman-Demir G, et al.: Headache in Behcet's disease. Cephalalgia 2006, 26:180-186.
29. Wechsler B, Vidailhet M, Piette JC, et al.: Cerebral venous thrombosis in Behcet's disease: clinical study and long-term follow-up of 25 cases. Neurology 1992, 42:614-618.
30. Ho CL, Deruytter MJ: Manifestations of Neuro-Behcet's disease: report of two cases and review of the literature. Clin Neurol Neurosurg 2005, 107:310-314.
31. Zelenski JD, Capraro JA, Holden D, Calabrese LH: Central nervous system vasculitis in Behcet's syndrome: angiographic improvement after therapy with cytotoxic agents. Arthritis Rheum 1989, 32:217-220.
32. Dong ZH, Fu WG, Guo DQ, et al.: Endovascular repair for a huge vertebral artery pseudoaneurysm caused by Behcet's disease. Chin Med J 2006, 119:435-437.
33. Yazici H, Yurdakul S, Hamuryudan V, Fresko I: Behçet's syndrome. In Rheumatology. Edited by Hochberg MC, Silman AJ, Smolen JS, et al.: Madrid, Spain: Mosby; 2003:1665-1669.
34. Reske D, Petereit HF, Heiss WD: Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system-value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand 2005, 112:207-213. Article describes a good study of the value of cerebrospinal fluid analysis in the differential diagnosis of immunologic conditions affecting the central nervous system.
35. Sharief MB, Hentges R, Thomas E: Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behcet's disease. Neurology 1991, 41:1398-1401.
36. Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, et al.: Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003, 145:127-134.
37. Akman-Demir G, Bahar S, Coban O, et al.: Cranial MRI in Behcet's disease: 134 examinations of 98 patients. Neuroradiology 2003, 45:851-859. Article reports in detail the cranial MRI findings of neuro-Behçet's syndrome.
38. Erdem H, Dinc A, Pay S, et al.: A neuro-Behcet's case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt. Joint Bone Spine 2006, 73:200-201.
39. Motomura S, Tabira T, Kuroiwa Y: A clinical comparative study of multiple sclerosis and neuro-Behcet's syndrome. J Neurol Neurosurg Psychiatry 1980, 43:210-213.
40. McLean BN, Miller D, Thompson EJ: Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995, 58:548-554.
41. Diri E, Espinoza CG, Espinoza LR: Spinal cord granulomatous vasculitis: an unusual clinical presentation of sarcoidosis. J Rheumatol 1999, 26:1408-1410.
42. Siva A, Kantarcy OH, Saip S, et al.: Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95-103.
43. Siva A, Fresko I I: Behcet's disease. Curr Treat Options Neurol 2000, 2:435-448.
44. O'Duffy JD, Robertson DM, Goldstein NP: Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet's disease. Am J Med 1984, 76:75-84.
45. Ranselaar CG, Boone RM, Kluin-Nelemans HC: Thalidomide in the treatment of neuro-Behcet's syndrome. Br J Dermatol 1986, 115:367-370.
46. Calguneri M, Ozturk MA, Ertenli I, et al.: Effects of interferon alpha treatment on the clinical course of refractory Behcet's disease: an open study. Ann Rheum Dis 2003, 62:492-493.
47. Sarwar H, McGrath H, Jr, Espinoza LR: Successful treatment of long-standing neuro-Behcet's disease with infliximab. J Rheumatol 2005, 32:181-183.
48. Ribi C, Sztajzel R, Delavelle J, Chizzolini C: Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behcet disease. J Neurol Neurosurg Psychiatry 2005, 76:1733-1735.
49. Wechsler B, Gerber S, Vidailhet M, Dormont D: Neurologic manifestations of Behcet's disease [in French]. Ann Med Interne 1999, 150:555-561.
50. Hirohata S, Suda H, Hashimoto T: Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease. J Neurol Sci 1998, 159:181-185.